In our study, elevated levels of IL-6, IL-10, and CCL5 seemed to be remarkable biomarkers for differentiating patients with severe COVID-19 from AS and NI patients, suggesting an association with progression to severe COVID-19. This evidence concerns the gene CCL5 and COVID-19.